Vioxx has an indication for treatment of acute pain; Celebrex does not _ it has been approved for the treatment of rheumatoid arthritis and osteoarthritis.
Even before the NIH study is off the drawing boards, leading US arthritis specialists are recommending glucosamine to their patients _ not as a cure, but as something that reduces pain in some people and may (or may not) retard the progress of the disease, depending on whether the European study results can be confirmed.
A different drug of the same type, Merck &AMP; Co.'s Vioxx, is awaiting approval by the Food and Drug Administration and could be on the market by summer.
I had arthritis.
``This is a strange, inverted application of the traditional scientific model,'' said Dr. Timothy McAlindon, an associate professor of medicine at Boston University who has analyzed the evidence on glucosamine and chondroitin sulfate, here and abroad.
But he said ``enough people are using it that if it works, we ought to know about it.
The drugs appear to be no more effective at fighting pain than traditional anti-inflammatory medications such as ibuprofen and aspirin, but offer the advantage of fewer side effects.
Some do, some don't.
Now 56, he was in his early 40s.
&UR; REMEDIES: Taking Vitamin E, for Better or for Worse &LR;
It involves a genetic abnormality in the body's immune system that causes inflammation in the lining of the joints that can damage cartilage and bone.
